Your browser doesn't support javascript.
loading
Efficacy of Mepolizumab Extended Interval Dosing for 2 Asthmatic Patients With Chronic Eosinophilic Pneumonia
Sato, H; Miyata, Y; Inoue, H; Tanaka, A; Sagara, H.
Affiliation
  • Sato, H; Showa University School of Medicine. Division of Respiratory Medicine and Allergology. Department of Internal Medicine. Tokyo. Japan
  • Miyata, Y; Showa University School of Medicine. Division of Respiratory Medicine and Allergology. Department of Internal Medicine. Tokyo. Japan
  • Inoue, H; Showa University School of Medicine. Division of Respiratory Medicine and Allergology. Department of Internal Medicine. Tokyo. Japan
  • Tanaka, A; Showa University School of Medicine. Division of Respiratory Medicine and Allergology. Department of Internal Medicine. Tokyo. Japan
  • Sagara, H; Showa University School of Medicine. Division of Respiratory Medicine and Allergology. Department of Internal Medicine. Tokyo. Japan
J. investig. allergol. clin. immunol ; 31(5): 459-460, 2021.
Article in En | IBECS | ID: ibc-216397
Responsible library: ES1.1
Localization: ES15.1 - BNCS
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
Search on Google

Full text: 1 Collection: 06-national / ES Database: IBECS Main subject: Pulmonary Eosinophilia / Asthma / Anti-Asthmatic Agents / Antibodies, Monoclonal, Humanized Limits: Adult / Female / Humans / Male Language: En Journal: J. investig. allergol. clin. immunol Year: 2021 Document type: Article
Fulltext
Add to My VHL
Print
XML
Search on Google

Full text: 1 Collection: 06-national / ES Database: IBECS Main subject: Pulmonary Eosinophilia / Asthma / Anti-Asthmatic Agents / Antibodies, Monoclonal, Humanized Limits: Adult / Female / Humans / Male Language: En Journal: J. investig. allergol. clin. immunol Year: 2021 Document type: Article